+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Modern approaches to investigating non-neuronal aspects of Alzheimer's disease



Modern approaches to investigating non-neuronal aspects of Alzheimer's disease



Faseb Journal 33(2): 1528-1535



The slow, continuous, devastating march of Alzheimer's disease continues to move across the globe. As a society, we are at a loss for options to treat or reverse the death of neurons-the final, apparently inescapable, hallmark of the disease. A continued focus on these dying neurons has taught us much about the disease but with no knowledge-based effective treatment in sight. A surge of interest in non-neuronal cells, including glia, blood vasculature, and immune cells, has shed new light on how we may better diagnose and treat patients. This may be our best hope to treat the millions patients with cognitive decline and memory loss.-Liddelow, S. A. Modern approaches to investigating non-neuronal aspects of Alzheimer's disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446035

Download citation: RISBibTeXText

PMID: 30703873

DOI: 10.1096/fj.201802592


Related references

Investigating poor insight in Alzheimer's disease: A survey of research approaches. Dementia 6(1): 45-61, 2007

Modern approaches to the therapy of Alzheimer's disease. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 98(12): 56-62, 1998

Neurobiology and modern approaches to the treatment of Alzheimer disease. Likars'ka Sprava 2004(7): 12-16, 2004

Investigating the neural correlates of pathological cortical networks in Alzheimer's disease using heterogeneous neuronal models. IEEE Transactions on Bio-Medical Engineering 59(3): 890-896, 2012

Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. Bmc Genomics 16: 84, 2016

Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer's disease. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 115(6): 103-114, 2015

Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products. Annals of the New York Academy of Sciences 1398(1): 130-141, 2017

Nutritional approaches to modulate oxidative stress that induce Alzheimer's disease. Nutritional approaches to prevent Alzheimer's disease. Gaceta Medica de Mexico 151(2): 245-251, 2015

Modern approaches for investigating epigenetic signaling pathways. Journal of Applied Physiology 109(3): 927-933, 2011

Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease. Journal of Pharmacological Sciences 118(3): 331-337, 2012

V642I APP-inducible neuronal cells: a model system for investigating Alzheimer's disorders. Biochemical and Biophysical Research Communications 274(2): 445-454, 2000

Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: possible involvement of HRD1, a novel molecule related to endoplasmic reticulum stress, in Alzheimer's disease. Journal of Pharmacological Sciences 118(3): 325-330, 2012

ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. Journal of Neuroinflammation 6: 41, 2010

Neuronal loss and neuronal atrophy. Computer simulation in connection with Alzheimer's disease. Brain Research 504(1): 94-100, 1989

Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 46(1): 28-39, 1987